Clinical trial
CROPSI Study A Randomized, Observer-blinded Clinical Trial Evaluating Effectiveness of Cryotherapy vs. Cryocompression for Preventing CIPN in Women Undergoing Chemotherapy
NCT04632797 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CROPSI Study A Randomized, Observer-blinded Clinical Trial Evaluating Effectiveness of Cryotherapy vs. Cryocompression for Preventing CIPN in Women Undergoing Chemotherapy
- Lead sponsor
- Medical University Innsbruck
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 3, 2020
- Completion date
- February 3, 2024
- Enrollment
- 196 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapeutic agent toxicity, chemotherapeutic toxicity, chemotherapy-induced peripheral neuropathy